Seegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private Placement

CALGARY, AB, Aug. 26, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV: SEGN) (“ Seegnal ” or the “ Company ”), a global leader in SaaS clinical decision support solutions, is pleased to announce, further to its news releases dated June 2, 2026 and July 21, 2026, that it has closed the first tranche (“ Tranche 1 ”) of its previously announced non-brokered private placement of units in the capital of the Company (each, a “ Unit ”). The Company is also pleased to announce that it has upsized the private placement to up to CDN$1,850,000 and is expected to close the second tranche by September 30, 2026.

The TSX Venture Exchange (the “ TSXV ”) has approved an extension and upsize for the Company to complete the non-brokered private placement for up to 6,607,143 Units for gross proceeds of up to CDN$1,850,000 at a price of $0.28 per Unit (the “ Upsized Offering ”). As such, the second and final tranche of the Upsized Offering is expected to close on or about September 30, 2026, subject to receipt of all regulatory approvals including the final approval of the TSXV and customary closing conditions.

A welcome email is on its way. If you don't see it, please check your junk folder.

Upon closing of Tranche 1, the Company has issued an aggregate of 1,486,500 Units for gross proceeds of CDN$416,220 at a price of CDN$0.28 per Unit. Each Unit is comprised of one common share in the capital of the Company (each, a “ Common Share ”) and one common share purchase warrant (each, a “ Warrant ”). Each Warrant is exercisable to acquire one Common Share at a price of CDN$0.50 for a period of 36 months. The proceeds from Tranche 1 will be used by the Company for general corporate and working capital purposes. No finders’ fees were paid in connection with the closing of Tranche 1. All securities issued under Tranche 1 are subject to a hold period expiring four months and one day from the date of issuance.

Related Party Disclosure Certain insiders subscribed for an aggregate of 1,486,500 Units in Tranche 1 (the “ Insiders ”), representing 100% of the Units sold in Tranche 1. The Insiders’ participation in the Upsized Offering constitutes a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“ MI 61-101 ”). Such participation by the Insiders is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities to be acquired by the Insiders, nor the consideration for the securities paid by such Insiders, exceed 25% of the Company’s market capitalization. The Company did not file a material change report at least 21 days in advance of the closing of Tranche 1 as the participation of such Insiders in the Upsized Offering had not been confirmed at that time.

About Seegnal Seegnal Inc. (TSXV: SEGN) is an innovative healthcare technology company dedicated to reducing medication-related harm where care begins.